Abstract
The promyelocytic leukemia protein PML acts as a tumor suppressor by forming transcription-regulatory complexes with a variety of repressor proteins. In the present study, we found that endogenous PML suppresses interleukin (IL)-6-induced gene expression as well as phosphorylation and transcriptional activation of STAT3 in hepatoma cells. We also found that PML-mediated suppression of IL-6-induced STAT3 activation by disrupting interactions between STAT3 and HDAC3. These results indicate that PML modulates IL-6-induced STAT3 activation and hepatoma cell growth by interacting with HDAC3.
Keywords:
HDAC3; Hepatoma; IL-6; PML; STAT3; Transcriptional regulation.
Copyright © 2015 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Carcinoma, Hepatocellular / genetics
-
Carcinoma, Hepatocellular / metabolism*
-
Cell Line, Tumor
-
Gene Expression Regulation, Neoplastic
-
Histone Deacetylases / metabolism*
-
Humans
-
Interleukin-6 / metabolism*
-
Liver Neoplasms / genetics
-
Liver Neoplasms / metabolism*
-
Nuclear Proteins / metabolism*
-
Promyelocytic Leukemia Protein
-
Protein Interaction Maps
-
STAT3 Transcription Factor / genetics
-
STAT3 Transcription Factor / metabolism*
-
Transcription Factors / metabolism*
-
Transcriptional Activation
-
Tumor Suppressor Proteins / metabolism*
Substances
-
Interleukin-6
-
Nuclear Proteins
-
Promyelocytic Leukemia Protein
-
STAT3 Transcription Factor
-
Transcription Factors
-
Tumor Suppressor Proteins
-
PML protein, human
-
Histone Deacetylases
-
histone deacetylase 3